Cargando…
Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
PURPOSE: To investigate the association between urinary complement proteins and renal outcome in biopsy-proven diabetic nephropathy (DN). METHODS: Untargeted proteomic and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional analyses and targeted proteomic analysis using parallel reaction-monit...
Autores principales: | Zhao, L., Zhang, Y., Liu, F., Yang, H., Zhong, Y., Wang, Y., Li, S., Su, Q., Tang, L., Bai, L., Ren, H., Zou, Y., Wang, S., Zheng, S., Xu, H., Li, L., Zhang, J., Chai, Z., Cooper, M. E., Tong, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572220/ https://www.ncbi.nlm.nih.gov/pubmed/34043214 http://dx.doi.org/10.1007/s40618-021-01596-3 |
Ejemplares similares
-
Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy
por: Lee, Wen-Chin, et al.
Publicado: (2020) -
Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
por: Zürbig, Petra, et al.
Publicado: (2012) -
Research: Complications Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy
por: Mise, K, et al.
Publicado: (2015) -
Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese Patients
por: Liao, Wen-Ling, et al.
Publicado: (2018) -
The CNDP1 (CTG)(5) Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration
por: Albrecht, Thomas, et al.
Publicado: (2017)